Chris Byrd

Dr. Byrd has served as the General Counsel since May 2022. Prior to joining us, Dr. Byrd was with Kite Pharma, Inc., a biotechnology company, where he served as Senior Associate General Counsel and led the corporate legal function from April 2019 to December 2021. Prior to that, Dr. Byrd practiced law at Wilson Sonsini Goodrich & Rosati PC for almost two decades where he specialized in complex business transaction in the biotechnology and pharmaceutical sectors. Dr. Byrd holds a BA in Philosophy from the University of Texas at Austin, a Ph.D. in Biology from Caltech and a J.D. from Stanford Law School.